FDA Removes 12 Peptides from 503A Category 2 Newtropin BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2. FDA is moving them to an independent scientific The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like FDA's 2026 Expectations: Clinical Decision Support Compliance